Latest Exalenz Bioscience Stories
- Nonalcoholic Steatohepatitis is a progressive liver disease associated with increased risk for liver cirrhosis, hepatocellular cancer, metabolic and cardiovascular disease - MODI'IN,
Study results support a test-and-treat strategy that could benefit symptomatic patients MODI'IN, Israel, April 13, 2015 /PRNewswire/ -- Exalenz Bioscience (TASE: EXEN), a leader in
MODI'IN, Israel, Sept.
Exalenz to Supply Innovative H. pylori Breath Testing Solution to Veterans Administration Hospitals and Clinics Wilmington, Del.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.